107 related articles for article (PubMed ID: 31305263)
1. Kaposi sarcoma-associated herpesvirus miRNAs suppress CASTOR1-mediated mTORC1 inhibition to promote tumorigenesis.
Li T; Ju E; Gao SJ
J Clin Invest; 2019 Jul; 129(8):3310-3323. PubMed ID: 31305263
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of arginine sensing by CASTOR1 upstream of mTORC1.
Saxton RA; Chantranupong L; Knockenhauer KE; Schwartz TU; Sabatini DM
Nature; 2016 Aug; 536(7615):229-33. PubMed ID: 27487210
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 Nef and KSHV oncogene K1 synergistically promote angiogenesis by inducing cellular miR-718 to regulate the PTEN/AKT/mTOR signaling pathway.
Xue M; Yao S; Hu M; Li W; Hao T; Zhou F; Zhu X; Lu H; Qin D; Yan Q; Zhu J; Gao SJ; Lu C
Nucleic Acids Res; 2014 Sep; 42(15):9862-79. PubMed ID: 25104021
[TBL] [Abstract][Full Text] [Related]
4. Folate-Targeted Nanocarriers Co-Deliver Ganciclovir and miR-34a-5p for Combined Anti-KSHV Therapy.
Li F; Cao D; Gu W; Li D; Liu Z; Cui L
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474177
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in KSHV-encoded microRNA sequences affect levels of mature viral microRNA in Kaposi Sarcoma lesions.
Marshall VA; Labo N; Sztuba-Solinska J; Cornejo Castro EM; Aleman K; Wyvill KM; McNamara L; Le Grice SFJ; Yarchoan R; Uldrick TS; MacPhail P; Polizzotto MN; Whitby D
Oncotarget; 2018 Nov; 9(88):35856-35869. PubMed ID: 30533200
[TBL] [Abstract][Full Text] [Related]
6. L-arginine alleviates heat stress-induced mammary gland injury through modulating CASTOR1-mTORC1 axis mediated mitochondrial homeostasis.
Gai Z; Hu S; He Y; Yan S; Wang R; Gong G; Zhao J
Sci Total Environ; 2024 May; 926():172017. PubMed ID: 38552976
[TBL] [Abstract][Full Text] [Related]
7. miR-769-3p inhibits cellular proliferation of KSHV-infected SH-SY5Y cells through targeting mTOR.
Cao D; Wu Z; Yang R; Yao L; Huang J; Ding Y; Ruzi A; Pan Z; Pan Y; Li D; Gu W; Zhang J
J Cancer; 2024; 15(11):3338-3349. PubMed ID: 38817860
[TBL] [Abstract][Full Text] [Related]
8. KSHV-Encoded MicroRNAs: Lessons for Viral Cancer Pathogenesis and Emerging Concepts.
Qin Z; Jakymiw A; Findlay V; Parsons C
Int J Cell Biol; 2012; 2012():603961. PubMed ID: 22505930
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of miR-34a-5p by phenylborate-coupled polyethylenimide nanocarriers for anti-KSHV treatment.
Li F; Cao D; Yao L; Gu W; Liu Z; Li D; Cui L
Front Bioeng Biotechnol; 2023; 11():1343956. PubMed ID: 38260739
[TBL] [Abstract][Full Text] [Related]
10. Synthetic lethality by targeting the RUVBL1/2-TTT complex in mTORC1-hyperactive cancer cells.
Shin SH; Lee JS; Zhang JM; Choi S; Boskovic ZV; Zhao R; Song M; Wang R; Tian J; Lee MH; Kim JH; Jeong M; Lee JH; Petukhov M; Lee SW; Kim SG; Zou L; Byun S
Sci Adv; 2020 Jul; 6(31):eaay9131. PubMed ID: 32789167
[TBL] [Abstract][Full Text] [Related]
11. TORSEL, a 4EBP1-based mTORC1 live-cell sensor, reveals nutrient-sensing targeting by histone deacetylase inhibitors.
Li C; Yi Y; Ouyang Y; Chen F; Lu C; Peng S; Wang Y; Chen X; Yan X; Xu H; Li S; Feng L; Xie X
Cell Biosci; 2024 Jun; 14(1):68. PubMed ID: 38824577
[TBL] [Abstract][Full Text] [Related]
12. Micro RNA Targets in HIV Latency: Insights into Novel Layers of Latency Control.
Heinson AI; Woo J; Mukim A; White CH; Moesker B; Bosque A; Spina CA; Woelk CH; Macarthur BD; Beliakova-Bethell N
AIDS Res Hum Retroviruses; 2021 Feb; 37(2):109-121. PubMed ID: 33045840
[TBL] [Abstract][Full Text] [Related]
13. HBx increases EGFR expression by inhibiting miR129-5p function.
Ochi M; Otsuka M; Maruyama R; Koike K
Biochem Biophys Res Commun; 2020 Aug; 529(2):198-203. PubMed ID: 32703411
[TBL] [Abstract][Full Text] [Related]
14. EBV microRNA-BHRF1-2-5p targets the 3'UTR of immune checkpoint ligands PD-L1 and PD-L2.
Cristino AS; Nourse J; West RA; Sabdia MB; Law SC; Gunawardana J; Vari F; Mujaj S; Thillaiyampalam G; Snell C; Gough M; Keane C; Gandhi MK
Blood; 2019 Dec; 134(25):2261-2270. PubMed ID: 31856276
[TBL] [Abstract][Full Text] [Related]
15. Relation between microRNA-21, transforming growth factor β and response to treatment among chronic hepatitis C patients.
Ghazy AA; Osman EM; Rashwan EA; Gaballah AH; Mostafa H; Tawfik S
J Med Virol; 2019 Dec; 91(12):2166-2173. PubMed ID: 31368531
[TBL] [Abstract][Full Text] [Related]
16. RNF167 activates mTORC1 and promotes tumorigenesis by targeting CASTOR1 for ubiquitination and degradation.
Li T; Wang X; Ju E; da Silva SR; Chen L; Zhang X; Wei S; Gao SJ
Nat Commun; 2021 Feb; 12(1):1055. PubMed ID: 33594058
[TBL] [Abstract][Full Text] [Related]
17. Hijacking of nucleotide biosynthesis and deamidation-mediated glycolysis by an oncogenic herpesvirus.
Wan Q; Tavakoli L; Wang TY; Tucker AJ; Zhou R; Liu Q; Feng S; Choi D; He Z; Gack MU; Zhao J
Nat Commun; 2024 Feb; 15(1):1442. PubMed ID: 38365882
[TBL] [Abstract][Full Text] [Related]
18. CHIP promotes CAD ubiquitination and degradation to suppress the proliferation and colony formation of glioblastoma cells.
Li G; Xiao K; Li Y; Gao J; He S; Li T
Cell Oncol (Dordr); 2023 Nov; ():. PubMed ID: 37982961
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia and hypoxia-inducible factors in Kaposi sarcoma-associated herpesvirus infection and disease pathogenesis.
Davis DA; Shrestha P; Yarchoan R
J Med Virol; 2023 Sep; 95(9):e29071. PubMed ID: 37665216
[TBL] [Abstract][Full Text] [Related]
20. Targeting FoxO proteins induces lytic reactivation of KSHV for treating herpesviral primary effusion lymphoma.
Lan J; Wang Y; Yue S; Xu D; Li Y; Peng X; Hu J; Ju E; He S; Li T
PLoS Pathog; 2023 Aug; 19(8):e1011581. PubMed ID: 37594999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
